NYSE - Nasdaq Real Time Price USD
Nevro Corp. (NVRO)
As of 3:45 PM EST. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 5 | 6 |
| Avg. Estimate | -0.79 | -0.97 | -2.35 | -2.59 |
| Low Estimate | -0.95 | -1.01 | -2.59 | -2.98 |
| High Estimate | -0.67 | -0.94 | -1.98 | -2.33 |
| Year Ago EPS | -0.14 | -0.75 | -2.03 | -2.35 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 11 | 15 | 15 |
| Avg. Estimate | 100.02M | 94.64M | 403.21M | 407.15M |
| Low Estimate | 98.4M | 88.37M | 401.37M | 383.1M |
| High Estimate | 101.28M | 105.15M | 407.13M | 420.3M |
| Year Ago Sales | 116.18M | 101.9M | 425.17M | 403.21M |
| Sales Growth (year/est) | -13.90% | -7.12% | -5.17% | 0.98% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.97 | -0.69 | -0.84 |
| EPS Actual | -0.14 | -0.75 | -0.45 | -0.53 |
| Difference | 0.32 | 0.22 | 0.23 | 0.3 |
| Surprise % | 69.97% | 23.02% | 33.98% | 36.14% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.79 | -0.97 | -2.35 | -2.59 |
| 7 Days Ago | -0.65 | -0.87 | -2.54 | -2.6 |
| 30 Days Ago | -0.65 | -0.87 | -2.54 | -2.6 |
| 60 Days Ago | -0.65 | -0.87 | -2.54 | -2.59 |
| 90 Days Ago | -0.65 | -0.87 | -2.54 | -2.59 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 3 | 2 |
| Up Last 30 Days | 1 | -- | 3 | 2 |
| Down Last 7 Days | 3 | 2 | 1 | 2 |
| Down Last 30 Days | 3 | 2 | 1 | 2 |
Growth Estimates
| CURRENCY IN USD | NVRO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -481.43% | -- | -- | 5.00% |
| Next Qtr. | -30.50% | -- | -- | 12.00% |
| Current Year | -15.75% | -- | -- | 2.10% |
| Next Year | -10.31% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Hold to Hold | 11/12/2024 |
| Reiterates | JMP Securities: Market Perform | 11/12/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 11/12/2024 |
| Maintains | Baird: Neutral to Neutral | 11/12/2024 |
| Maintains | Piper Sandler: Underweight to Underweight | 11/12/2024 |
| Maintains | Citigroup: Neutral to Neutral | 10/1/2024 |
Related Tickers
PEN Penumbra, Inc.
244.08
+1.49%
SGHT Sight Sciences, Inc.
4.0550
+7.85%
IRTC iRhythm Technologies, Inc.
73.68
-0.30%
NARI Inari Medical, Inc.
49.60
-0.30%
INSP Inspire Medical Systems, Inc.
188.00
+0.97%
LIVN LivaNova PLC
51.11
-1.14%
BSX Boston Scientific Corporation
89.87
-1.78%
QTI QT Imaging Holdings, Inc.
0.4797
-6.49%
SIBN SI-BONE, Inc.
12.54
+2.03%
AVNS Avanos Medical, Inc.
18.54
+2.86%